Vol 1 (November 2017): Mediastinum

ITMIG 2017—Prof. Patrick Loehrer: conduct more clinical trials to get more helpful information and benefits patients

Robotic thymectomy

Single missense mutation as a signal of indolent thymic epithelial tumors: General Transcription Factor II-I (GTF2I)

Lymph nodes metastases in thymic malignancies: we need prospective studies

GTF2I gene mutation—a driver of thymoma pathogenesis

Optimal therapy for thymic epithelial tumors with pleural involvement

Specific mutations in thymic epithelial tumors

Balance between less invasiveness and radical capability with safety

Editorial on “assessment of the ITMIG statement on the WHO histological classification and of the 8th TNM staging of thymic epithelial tumors, of a series of 188 thymic epithelial tumors”